Neurotrophins regulate cholinergic synaptic transmission in cultured rat sympathetic neurons through a p75-dependent mechanism

• Published in: Journal of neurophysiology Vol. 109; no. 2; pp. 485 - 496
• Main Authors: Luther, J A, Enes, J, Birren, S J
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.01.2013
• Subjects: Animals; Brain-Derived Neurotrophic Factor - metabolism; Brain-Derived Neurotrophic Factor - pharmacology; Cholinergic Neurons - physiology; Coculture Techniques; Excitatory Postsynaptic Potentials - drug effects; Fumonisins - pharmacology; Myocytes, Cardiac - physiology; Nerve Growth Factor - metabolism; Nerve Growth Factor - pharmacology; Rats; Receptor, Nerve Growth Factor - metabolism; Sphingosine - analogs & derivatives; Sphingosine - pharmacology; Superior Cervical Ganglion - cytology; Superior Cervical Ganglion - physiology
• ISSN: 0022-3077; 1522-1598
• DOI: 10.1152/jn.00076.2011

The sympathetic nervous system regulates many essential physiological systems, and its dysfunction is implicated in cardiovascular diseases. Mechanisms that control the strength of sympathetic output are therefore potential targets for the management of these disorders. Here we show that neurotrophins rapidly potentiate cholinergic transmission between cultured rat sympathetic neurons. We found that brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), acting at the p75 receptor, increased the amplitude of excitatory postsynaptic currents (EPSCs). We observed increased amplitude but not frequency of miniature synaptic currents after p75 activation, suggesting that p75 acts postsynaptically to modulate transmission at these synapses. This neurotrophic modulation enhances cholinergic EPSCs via sphingolipid signaling. Application of sphingolactone-24, an inhibitor of neutral sphingomyelinase, blocked the effect of BDNF, implicating a sphingolipid pathway. Furthermore, application of the p75-associated sphingolipid second messengers C(2)-ceramide and d-erythro-sphingosine restricted to the postsynaptic cell mimicked BDNF application. Postsynaptic blockade of ceramide production with fumonisin, a ceramide synthase inhibitor, blocked the effects of BDNF and d-erythro-sphingosine, implicating ceramide or ceramide phosphate as the active signal. Together these data suggest that neurotrophin signaling, which occurs in vivo via release from sympathetic neurons and target tissues such as the heart, acutely regulates the strength of the sympathetic postganglionic response to central cholinergic inputs. This pathway provides a potential mechanism for modulating the strength of sympathetic drive to target organs such as the heart and could play a role in the development of cardiovascular diseases.